FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to structure compounds
, as well as to their pharmaceutically acceptable salts.
EFFECT: technical result: new compounds are obtained that are inhibitors of IAP proteins, as well as pharmaceutical compositions based on them, suitable for treatment of diseases and conditions, in which inhibition of IAP protein provides a benefit, like cancers.
14 cl, 1 dwg, 50 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BENZIMIDAZOLE-2-PIPERAZINE HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2649002C2 |
| PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
| METHOD FOR PRODUCING AN ACETYLCHOLINESTERASE (AChE) INHIBITOR AND INHIBITOR PRODUCED BY THE METHOD | 2021 |
|
RU2779555C1 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| NEW SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS AS INDOLEAMINE-2,3-DIOXYGENASE AND/OR TRYPTOPHAN-2,3-DIOXYGENASE INHIBITORS | 2017 |
|
RU2741911C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
| CXCR7 ANTAGONISTS | 2013 |
|
RU2649004C2 |
| FIVE-MEMBERED HETEROCYCLIC PYRIDINE COMPOUNDS AND PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2668074C2 |
| CYCLOBUTYL (S)-2-[[[R)-2-(6-AMINOPURIN-9-YL)-1-METHYL-ETOXY]METHYL-PHENOXY-PHOSPHORYL]AMINO]-PROPANOATES, METHOD OF THEIR PRODUCTION AND APPLICATION | 2017 |
|
RU2647576C1 |
